PMA device
Menicon Sf-P (Tm)
Menicon Co, Ltd. · Lens, Contact (Other Material) - Daily (HQD, Class II) · First FDA decision May 19, 2000, newest Sep 6, 2000Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "Menicon Sf-P"
MAUDE reports
0
Brand "Menicon Sf-P", since 2015
PubMed studies
5
Mentioning "Menicon Sf-P"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Menicon Sf-P (Tm)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- MENICON SF-P (TM)PMA supplement
P880098-S011 · Decided Sep 6, 2000 · 85 days after receipt · Normal 180 Day Track
Device type: Lens, contact (other material) - daily (HQD) · Ophthalmology
- MENICON SF-P510(k)
K000233 · Decided May 19, 2000 · 113 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Menicon Sf-P", any status and sponsor, newest update first.
No registered device study names "Menicon Sf-P".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Menicon Sf-P", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HQD
37 reports: 3 malfunction, 34 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Menicon Sf-P"[tiab]. The summary above synthesizes these.
- A prospective multicenter clinical trial to assess safety and efficacy of Menicon SF-P RGP lenses for extended wear.
MacKeen DL, Sachdev M, Ballou V, et al. · CLAO J · 1992Clinical Trial, Multicenter Study
- The effects of high-Dk rigid contact lens center thickness, material permeability, and blinking on the oxygen uptake of the human cornea.
Gardner HP, Fink BA, Mitchell LG, et al. · Optom Vis Sci · 2005
- Tear lactate dehydrogenase levels. A new method to assess effects of contact lens wear in man.
Ichijima H, Imayasu M, Ohashi J, et al. · Cornea · 1992Comparative Study, Research Support, Non-U.S. Gov't
- Corneal swelling responses with extended wear in naive and adapted subjects with menicon RGP contact lenses.
Ichikawa H, Kozai A, MacKeen DL, et al. · CLAO J · 1989Clinical Trial, Comparative Study
- Swelling and deswelling of rabbit corneas in response to rigid gas permeable, hydrogel and elastomer contact lens wear.
Hideji I, MacKeen DL, Hamano H, et al. · CLAO J · 1989Comparative Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code HQD.
- OPTIMUM GP (roflufocon D, roflurocon E) Daily Wear Contact LensContamac, Ltd. · 510(k) 2018
- Synergeyes Hybrid Contact Lenses - Daily Wear, Models A, M, Kc and PsSynergeyes, Inc. · 510(k) 2008
- Rigid Gas Permeable Contact Lens SolutionPolymer Technology Corp. · 510(k) 2001
- Acuity 200 (fluoroxyfocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. · 510(k) 2024
- Visionary Optics Scleral Contact Lens (roflufocon D, roflufocon E, hexafocon A, hexafocon B, tisilfocon A, fluoroxyfocon A)Visionary Optics, LLC · 510(k) 2024
- Custom Stable Rigid Gas Permeable Scleral Contact LensValley Contax, Inc. · 510(k) 2022
- Acuity 18 (enflufocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. · 510(k) 2018
- FluoroPerm 30 & Paragon Thin (paflufocon C) RGP contact lenses with Tangible Hydra-PEGParagon Vision Sciences · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.